 | | | | | | |
|---|
 | 2014 |
| |
| 2015 |
| |
| 2016 |
| |
 | 2017 |
| |
| 01 |
| |
| 02 |
| |
| 03 |
| |
| 04 |
| |
| 05 |
| |
| 06 |
| |
| | 06/29/2017 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, and Industry Partners Create New Automotive Coating Effects |  | |
| | 06/26/2017 | 09:00 AM | | Displaying Futures Award Attracts High Interest |  | |
| | 06/26/2017 | 02:00 PM | | MilliporeSigma adds Chemical Products to Reaxys’ Chemistry Database | | |
| | 06/23/2017 | 01:40 PM | | Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis | | |
| | 06/22/2017 | 12:00 PM | | Merck KGaA, Darmstadt, Germany, Pigment Innovation at the Laser World of Photonics 2017 | | |
| | 06/20/2017 | 02:00 PM | | Corporate Ventures Fund of Merck KGaA, Darmstadt, Germany, Creates New Immuno-Oncology Company iOnctura | | |
| | 06/15/2017 | 02:00 PM | | MilliporeSigma Expands Distribution Agreement with Public Health England | | |
| | 06/14/2017 | 02:00 PM | | MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office | | |
| | 06/04/2017 | 01:15 PM | | Merck KGaA, Darmstadt, Germany Strengthens Immuno-Oncology Portfolio through Expansion of F-star Collaboration including LAG-3/PD-L1 Bispecific Antibody | | |
| 07 |
| |
| 08 |
| |
| 09 |
| |
| 10 |
| |
| 11 |
| |
| 12 |
| |
| 2018 |
| |